Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA
18/07/2025 11:25
July 18 (Reuters) - Uni-Bio Science Group Ltd 0690.HK: MARKETING APPLICATION OF ISAVUCONAZONIUM- SULFATE CAPSULES HAS BEEN OFFICIALLY ACCEPTED- BY NMPA Further company coverage: 0690.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Uni-Bio Science
See all newsUni-Bio Science H1 revenue falls 12% on pricing changes
Brief: Uni-Bio Science Expects Net Profit Of Hk$30 Million For Six Months Ended June 2026
Brief: Uni-Bio Science Signs Agreement With WMU NERC And Wenzhou Ouhai District Government
Brief: Uni-Bio Science's Unit Expands Global Reach Of Bogutai Through Strategic Partnership
Brief: Uni-Bio Science Group Says Marketing Application Of Isavuconazonium- Sulfate Capsules Accepted NMPA